The Effect of Differing Kidney Disease Treatment Modalities and Organ Donation and Transplantation Practices on Health Expenditure and Patient Outcomes (EDITH)
Practices on Health Expenditure and Patient Outcomes (EDITH)
Grant agreement PP-1-2016 Pilot project of the European Parliament on chronic kidney disease
Chronic kidney diseases (CKD) are the cause of substantial morbidity and mortality and result in a major burden both to the individual patients and society as a whole. There are different treatment options, kidney transplantation being one of them. There is an enormous variability in the overall management of CKD and in the access to transplantation in particular within the European Union (EU) Member States. In order to provide equal access to good quality care, while simultaneously reducing its costs, an alignment of procedures and practices in the treatment of CKD is considered an important goal. In line with EU policies and legislation in the field of chronic diseases and organ transplantation, EDITH aims to assess the different treatment modalities for chronic kidney diseases currently used in the EU and the factors influencing the treatment choices by patients and doctors.
In order to achieve the overall objective, the project wants to examine the effect of differing kidney disease treatment modalities and organ donation and transplantation practices on health expenditure and patient outcomes.
By supporting the establishment of registries to follow-up living donors as well as transplant recipients, at minima at national levels and in addition also at European level, crucial information to increase the quality and safety of living donors and all transplant recipients will be gathered. This should provide more information on the possibilities of improving donation and transplantation outcomes and rates, thereby improving overall quality of care of patients with CKD.
Core work-packages will be devoted to:
WP4 – Assessment of different treatment modalities for CKD
Preparation of an overview on different treatment modalities for CKD focusing on:
a comparison, from a micro- and macro-economic perspective, of the various treatment modalities for CKD in EU Member States and associated countries (Iceland, Norway, Turkey, Switzerland)
factors that influence the selection of those modalities in Member States and associated countries (Iceland, Norway, Turkey, Switzerland)
factors that influence the treatment choice from the patients’ or doctors’ perceptive
impact of treatment choice on healthcare budgets
The Italian National Transplant Centre is co-leader of WP4 together with the Academisch Medisch Centrum on behalf of the European Renal Association – European Dyalisis and Transplant Association (ERA-EDTA) and will be in charge of the evaluation and analysis of impact of costs of different treatment options for CKD.
WP5 – Establishment of registries to follow-up living donors
WP 5 will support the establishment by EU Member States (MS) of registries to follow-up living kidney donors, in line with Article 15 of Directive 2010/53/EU. This WP will support MS in building up their national systems to follow-up living donors, and for MS interested (and beyond), in the development and implementation of a common, supranational tool to share their data. Such operational tool will be based on the experience learned and recommendations formulated by previous EU-funded projects (e.g. ACCORD Joint Action).
WP6 – Establishment of follow-up registers for transplant recipients
Establishment of an operational supranational tool (register) to follow-up transplant recipients. The main objective of this work package is therefore to provide for the establishment of a follow up registry of kidney organ transplant recipients in all Member States. Additionally, information on the quality of life of transplant recipients will enable the benefits of transplantation to be more broadly evaluated. Such operational tool will be based on the experience learned and recommendations formulated by previous EU-funded projects (e.g. EFRETOS).